Literature DB >> 26825044

Exploring the Role of Polycythemia in Patients With Cyanosis After Palliative Congenital Heart Surgery.

Stephanie L Siehr1, Shenghui Shi, Shiying Hao, Zhongkai Hu, Bo Jin, Frank Hanley, Vadiyala Mohan Reddy, Doff B McElhinney, Xuefeng Bruce Ling, Andrew Y Shin.   

Abstract

OBJECTIVES: To understand the relationship between polycythemia and clinical outcome in patients with hypoplastic left heart syndrome following the Norwood operation.
DESIGN: A retrospective, single-center cohort study.
SETTING: Pediatric cardiovascular ICU, university-affiliated children's hospital. PATIENTS: Infants with hypoplastic left heart syndrome admitted to our medical center from September 2009 to December 2012 undergoing stage 1/Norwood operation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Baseline demographic and clinical information including first recorded postoperative hematocrit and subsequent mean, median, and nadir hematocrits during the first 72 hours postoperatively were recorded. The primary outcomes were in-hospital mortality and length of hospitalization. Thirty-two patients were included in the analysis. Patients did not differ by operative factors (cardiopulmonary bypass time and cross-clamp time) or traditional markers of severity of illness (vasoactive inotrope score, lactate, saturation, and PaO2/FIO2 ratio). Early polycythemia (hematocrit value > 49%) was associated with longer cardiovascular ICU stay (51.0 [± 38.6] vs 21.4 [± 16.2] d; p < 0.01) and total hospital length of stay (65.0 [± 46.5] vs 36.1 [± 20.0] d; p = 0.03). In a multivariable analysis, polycythemia remained independently associated with the length of hospitalization after controlling for the amount of RBC transfusion (weight, 4.36 [95% CI, 1.35-7.37]; p < 0.01). No difference in in-hospital mortality rates was detected between the two groups (17.6% vs 20%).
CONCLUSIONS: Early polycythemia following the Norwood operation is associated with longer length of hospitalization even after controlling for blood cell transfusion practices. We hypothesize that polycythemia may be caused by hemoconcentration and used as an early marker of capillary leak syndrome.

Entities:  

Mesh:

Year:  2016        PMID: 26825044     DOI: 10.1097/PCC.0000000000000654

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  5 in total

1.  Fluid overload independent of acute kidney injury predicts poor outcomes in neonates following congenital heart surgery.

Authors:  Kenneth E Mah; Shiying Hao; Scott M Sutherland; David M Kwiatkowski; David M Axelrod; Christopher S Almond; Catherine D Krawczeski; Andrew Y Shin
Journal:  Pediatr Nephrol       Date:  2017-11-11       Impact factor: 3.714

2.  Complications of Transthoracic Intracardiac and Central Venous Lines in Neonates Undergoing Cardiac Surgery.

Authors:  Mary Lyn Stein; Luis G Quinonez; James A DiNardo; Morgan L Brown
Journal:  Pediatr Cardiol       Date:  2019-01-30       Impact factor: 1.655

3.  First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery.

Authors:  Anne Kerling; Okan Toka; André Rüffer; Hanna Müller; Sheeraz Habash; Christel Weiss; Sven Dittrich; Julia Moosmann
Journal:  BMC Pediatr       Date:  2019-02-12       Impact factor: 2.125

4.  Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in Taiwan.

Authors:  Ho-Chang Kuo; Shiying Hao; Bo Jin; C James Chou; Zhi Han; Ling-Sai Chang; Ying-Hsien Huang; Kuoyuan Hwa; John C Whitin; Karl G Sylvester; Charitha D Reddy; Henry Chubb; Scott R Ceresnak; John T Kanegaye; Adriana H Tremoulet; Jane C Burns; Doff McElhinney; Harvey J Cohen; Xuefeng B Ling
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

5.  Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes.

Authors:  Felina K Mille; Aditya Badheka; Priscilla Yu; Xuemei Zhang; David F Friedman; John Kheir; Sarah van den Bosch; Antonio G Cabrera; Javier J Lasa; Hannah Katcoff; Paula Hu; Santiago Borasino; Krissie Hock; Jordan Huskey; Jamie Weller; Harsh Kothari; Joshua Blinder
Journal:  J Am Heart Assoc       Date:  2020-05-11       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.